naltrexone has been researched along with Morbid Obesity in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kraft, K; Vetter, H | 1 |
1 review(s) available for naltrexone and Morbid Obesity
Article | Year |
---|---|
Naltrexone/bupropion for obesity.
Topics: Anti-Obesity Agents; Bupropion; Chemotherapy, Adjuvant; Drug Combinations; Humans; Naltrexone; Obesity, Morbid; Randomized Controlled Trials as Topic | 2017 |
1 other study(ies) available for naltrexone and Morbid Obesity
Article | Year |
---|---|
Long-term opiate receptor antagonism in a patient with panhypopituitarism: effects on appetite, prolactin and demand for vasopressin.
Topics: Adult; Appetite; Drug Administration Schedule; Female; Humans; Hypopituitarism; Naltrexone; Obesity, Morbid; Prolactin; Vasopressins; Weight Loss | 1991 |